Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Selective Mutism in Children
NCT05378711Phase 2Completed
- Sponsor
- Michigan State University
- Start
- Jan 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of fluoxetine in selective mutism (SM) and Social Anxiety Disorder (SAD), sponsored by Michigan State University. Primary endpoint: Selective Mutism Questionnaire at 15 weeks. Started Jan 2014; status: completed.
02
Drugs
fluoxetine
03
Conditions
selective mutism (SM)Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT05378711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05378711.